epirubicin has been researched along with Androblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carinelli, S; Maggioni, A; Peiretti, M; Rosenberg, P; Zanagnolo, V | 1 |
| Fujimoto, A; Ishihara, O; Itoyama, S; Kinoshita, K; Saitou, M; Takeda, S | 1 |
1 review(s) available for epirubicin and Androblastoma
| Article | Year |
|---|---|
Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor: a case report and review of literature.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Humans; Ifosfamide; Neoplasms, Multiple Primary; Ovarian Neoplasms; Prolactin; Sarcoma; Sertoli-Leydig Cell Tumor; Testosterone; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2012 |
1 other study(ies) available for epirubicin and Androblastoma
| Article | Year |
|---|---|
[A case of ovarian malignant Sertoli-Leidig cell tumor treated with CBDCA, etoposide and epirubicin chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Remission Induction; Sertoli-Leydig Cell Tumor | 1995 |